ITC News Today

LTIMindtree Board declares interim dividend of Rs 20

Copy Link

The interim dividend shall be paid within 30 days of declaration.

• 23 January, 2023
• 2:41 PM
• less than a minute

Trent signs JV with MAS Amity for intimate wear and related products

Copy Link

Over time, Trent and MAS would pool their domain expertise to undertake design, development and manufacturing.

• 23 January, 2023
• 9:16 AM
• less than a minute

Asian Paints stock plunges near 2% post Q3FY23 numbers

Copy Link

Consolidated Sales for the quarter increased by 1.7%.

• 20 January, 2023
• 9:16 AM
• less than a minute

Allox to set up an active battery material manufacturing unit in Telangana

Copy Link

The state-of-the-art facility for manufacturing C-LFP will cost Rs210 crore with an initial capacity of 3GWH/PA.

• 18 January, 2023
• 1:16 PM
• less than a minute

ITC announces acquisition of Yoga bar to bolster presence in nutrition health foods space

Copy Link

By February 15, the company will invest upto Rs175 crore by subscribing to shares representing a 39.4% stake in the startup.

• 18 January, 2023
• 9:49 AM
• less than a minute

Tech Mahindra to announce its Q3FY23 numbers on January 30

Copy Link

The stock hit an intraday high of Rs1051 per share and intraday low of Rs1046.40 per share on the BSE.

• 18 January, 2023
• 9:18 AM
• less than a minute

Google-backed Dunzo lays off 3% workforce

Copy Link

Dunzo last raised $240 million in January 2022 in a funding round led by Reliance Retail Ventures Ltd.

• 17 January, 2023
• 1:37 PM
• less than a minute

Nifty FMCG index gains 1% as heavyweights lift the index; HUL, Radico, ITC top gainers

Copy Link

Radico stock gained over 2.1%, while Godrej Consumer Products surged 0.9%.

• 17 January, 2023
• 10:35 AM
• less than a minute

NTPC REL ink agreement for collaboration on green energy projects in Tripura

Copy Link

The agreement is for the development of Floating and Ground Mounted based Renewable Energy Projects in the State of Tripura.

• 17 January, 2023
• 8:37 AM
• less than a minute

Dr Reddy's launches palbociclib to widen access to high-quality breast cancer drug

Copy Link

Dr Reddy’s is amongst select companies in the world to have conducted a bioequivalence study and received tentative approval from the USFDA for palbociclib.

• 16 January, 2023
• 9:17 AM
• less than a minute